HEADER MEMBRANE PROTEIN 14-APR-23 8J2F TITLE HUMAN NEUTRAL SHPINGOMYELINASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SPHINGOMYELIN PHOSPHODIESTERASE 2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: LYSO-PLATELET-ACTIVATING FACTOR-PHOSPHOLIPASE C,LYSO-PAF- COMPND 5 PLC,NEUTRAL SPHINGOMYELINASE,N-SMASE,NSMASE,NSMASE1; COMPND 6 EC: 3.1.4.12; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SMPD2; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS ENZYME, MEMBRANE PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR S.S.ZHANG REVDAT 2 01-MAY-24 8J2F 1 JRNL REVDAT 1 06-DEC-23 8J2F 0 JRNL AUTH J.YI,B.QI,J.YIN,R.LI,X.CHEN,J.HU,G.LI,S.ZHANG,Y.ZHANG,M.YANG JRNL TITL MOLECULAR BASIS FOR THE CATALYTIC MECHANISM OF HUMAN NEUTRAL JRNL TITL 2 SPHINGOMYELINASES 1 (HSMPD2). JRNL REF NAT COMMUN V. 14 7755 2023 JRNL REFN ESSN 2041-1723 JRNL PMID 38012235 JRNL DOI 10.1038/S41467-023-43580-W REMARK 2 REMARK 2 RESOLUTION. 3.07 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.070 REMARK 3 NUMBER OF PARTICLES : 220000 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8J2F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 18-APR-23. REMARK 100 THE DEPOSITION ID IS D_1300037062. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : HUMAN NEUTRAL SPHINGOMYELINASES REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.20 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1200.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 LYS A 2 REMARK 465 PRO A 285 REMARK 465 PRO A 286 REMARK 465 GLN A 287 REMARK 465 GLN A 288 REMARK 465 ASN A 289 REMARK 465 PRO A 290 REMARK 465 SER A 291 REMARK 465 SER A 292 REMARK 465 THR A 293 REMARK 465 HIS A 294 REMARK 465 GLY A 295 REMARK 465 PRO A 296 REMARK 465 ALA A 297 REMARK 465 GLU A 298 REMARK 465 ARG A 299 REMARK 465 LEU A 402 REMARK 465 GLY A 403 REMARK 465 PRO A 404 REMARK 465 GLU A 405 REMARK 465 PRO A 406 REMARK 465 GLN A 407 REMARK 465 PRO A 408 REMARK 465 ALA A 409 REMARK 465 LEU A 410 REMARK 465 LEU A 411 REMARK 465 LEU A 412 REMARK 465 GLY A 413 REMARK 465 GLN A 414 REMARK 465 GLN A 415 REMARK 465 GLU A 416 REMARK 465 GLY A 417 REMARK 465 ASP A 418 REMARK 465 ARG A 419 REMARK 465 THR A 420 REMARK 465 LYS A 421 REMARK 465 GLU A 422 REMARK 465 GLN A 423 REMARK 465 MET B 1 REMARK 465 LYS B 2 REMARK 465 PRO B 285 REMARK 465 PRO B 286 REMARK 465 GLN B 287 REMARK 465 GLN B 288 REMARK 465 ASN B 289 REMARK 465 PRO B 290 REMARK 465 SER B 291 REMARK 465 SER B 292 REMARK 465 THR B 293 REMARK 465 HIS B 294 REMARK 465 GLY B 295 REMARK 465 PRO B 296 REMARK 465 ALA B 297 REMARK 465 GLU B 298 REMARK 465 ARG B 299 REMARK 465 LEU B 402 REMARK 465 GLY B 403 REMARK 465 PRO B 404 REMARK 465 GLU B 405 REMARK 465 PRO B 406 REMARK 465 GLN B 407 REMARK 465 PRO B 408 REMARK 465 ALA B 409 REMARK 465 LEU B 410 REMARK 465 LEU B 411 REMARK 465 LEU B 412 REMARK 465 GLY B 413 REMARK 465 GLN B 414 REMARK 465 GLN B 415 REMARK 465 GLU B 416 REMARK 465 GLY B 417 REMARK 465 ASP B 418 REMARK 465 ARG B 419 REMARK 465 THR B 420 REMARK 465 LYS B 421 REMARK 465 GLU B 422 REMARK 465 GLN B 423 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 265 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 265 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 100 72.27 -102.59 REMARK 500 ALA A 353 12.89 50.52 REMARK 500 LEU B 100 72.27 -102.52 REMARK 500 ALA B 353 12.87 50.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 501 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 49 OE1 REMARK 620 2 GLU A 49 OE2 48.3 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 502 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU B 49 OE1 REMARK 620 2 GLU B 49 OE2 48.3 REMARK 620 N 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-35948 RELATED DB: EMDB REMARK 900 HUMAN NEUTRAL SHPINGOMYELINASE DBREF 8J2F A 1 423 UNP O60906 NSMA_HUMAN 1 423 DBREF 8J2F B 1 423 UNP O60906 NSMA_HUMAN 1 423 SEQRES 1 A 423 MET LYS PRO ASN PHE SER LEU ARG LEU ARG ILE PHE ASN SEQRES 2 A 423 LEU ASN CYS TRP GLY ILE PRO TYR LEU SER LYS HIS ARG SEQRES 3 A 423 ALA ASP ARG MET ARG ARG LEU GLY ASP PHE LEU ASN GLN SEQRES 4 A 423 GLU SER PHE ASP LEU ALA LEU LEU GLU GLU VAL TRP SER SEQRES 5 A 423 GLU GLN ASP PHE GLN TYR LEU ARG GLN LYS LEU SER PRO SEQRES 6 A 423 THR TYR PRO ALA ALA HIS HIS PHE ARG SER GLY ILE ILE SEQRES 7 A 423 GLY SER GLY LEU CYS VAL PHE SER LYS HIS PRO ILE GLN SEQRES 8 A 423 GLU LEU THR GLN HIS ILE TYR THR LEU ASN GLY TYR PRO SEQRES 9 A 423 TYR MET ILE HIS HIS GLY ASP TRP PHE SER GLY LYS ALA SEQRES 10 A 423 VAL GLY LEU LEU VAL LEU HIS LEU SER GLY MET VAL LEU SEQRES 11 A 423 ASN ALA TYR VAL THR HIS LEU HIS ALA GLU TYR ASN ARG SEQRES 12 A 423 GLN LYS ASP ILE TYR LEU ALA HIS ARG VAL ALA GLN ALA SEQRES 13 A 423 TRP GLU LEU ALA GLN PHE ILE HIS HIS THR SER LYS LYS SEQRES 14 A 423 ALA ASP VAL VAL LEU LEU CYS GLY ASP LEU ASN MET HIS SEQRES 15 A 423 PRO GLU ASP LEU GLY CYS CYS LEU LEU LYS GLU TRP THR SEQRES 16 A 423 GLY LEU HIS ASP ALA TYR LEU GLU THR ARG ASP PHE LYS SEQRES 17 A 423 GLY SER GLU GLU GLY ASN THR MET VAL PRO LYS ASN CYS SEQRES 18 A 423 TYR VAL SER GLN GLN GLU LEU LYS PRO PHE PRO PHE GLY SEQRES 19 A 423 VAL ARG ILE ASP TYR VAL LEU TYR LYS ALA VAL SER GLY SEQRES 20 A 423 PHE TYR ILE SER CYS LYS SER PHE GLU THR THR THR GLY SEQRES 21 A 423 PHE ASP PRO HIS ARG GLY THR PRO LEU SER ASP HIS GLU SEQRES 22 A 423 ALA LEU MET ALA THR LEU PHE VAL ARG HIS SER PRO PRO SEQRES 23 A 423 GLN GLN ASN PRO SER SER THR HIS GLY PRO ALA GLU ARG SEQRES 24 A 423 SER PRO LEU MET CYS VAL LEU LYS GLU ALA TRP THR GLU SEQRES 25 A 423 LEU GLY LEU GLY MET ALA GLN ALA ARG TRP TRP ALA THR SEQRES 26 A 423 PHE ALA SER TYR VAL ILE GLY LEU GLY LEU LEU LEU LEU SEQRES 27 A 423 ALA LEU LEU CYS VAL LEU ALA ALA GLY GLY GLY ALA GLY SEQRES 28 A 423 GLU ALA ALA ILE LEU LEU TRP THR PRO SER VAL GLY LEU SEQRES 29 A 423 VAL LEU TRP ALA GLY ALA PHE TYR LEU PHE HIS VAL GLN SEQRES 30 A 423 GLU VAL ASN GLY LEU TYR ARG ALA GLN ALA GLU LEU GLN SEQRES 31 A 423 HIS VAL LEU GLY ARG ALA ARG GLU ALA GLN ASP LEU GLY SEQRES 32 A 423 PRO GLU PRO GLN PRO ALA LEU LEU LEU GLY GLN GLN GLU SEQRES 33 A 423 GLY ASP ARG THR LYS GLU GLN SEQRES 1 B 423 MET LYS PRO ASN PHE SER LEU ARG LEU ARG ILE PHE ASN SEQRES 2 B 423 LEU ASN CYS TRP GLY ILE PRO TYR LEU SER LYS HIS ARG SEQRES 3 B 423 ALA ASP ARG MET ARG ARG LEU GLY ASP PHE LEU ASN GLN SEQRES 4 B 423 GLU SER PHE ASP LEU ALA LEU LEU GLU GLU VAL TRP SER SEQRES 5 B 423 GLU GLN ASP PHE GLN TYR LEU ARG GLN LYS LEU SER PRO SEQRES 6 B 423 THR TYR PRO ALA ALA HIS HIS PHE ARG SER GLY ILE ILE SEQRES 7 B 423 GLY SER GLY LEU CYS VAL PHE SER LYS HIS PRO ILE GLN SEQRES 8 B 423 GLU LEU THR GLN HIS ILE TYR THR LEU ASN GLY TYR PRO SEQRES 9 B 423 TYR MET ILE HIS HIS GLY ASP TRP PHE SER GLY LYS ALA SEQRES 10 B 423 VAL GLY LEU LEU VAL LEU HIS LEU SER GLY MET VAL LEU SEQRES 11 B 423 ASN ALA TYR VAL THR HIS LEU HIS ALA GLU TYR ASN ARG SEQRES 12 B 423 GLN LYS ASP ILE TYR LEU ALA HIS ARG VAL ALA GLN ALA SEQRES 13 B 423 TRP GLU LEU ALA GLN PHE ILE HIS HIS THR SER LYS LYS SEQRES 14 B 423 ALA ASP VAL VAL LEU LEU CYS GLY ASP LEU ASN MET HIS SEQRES 15 B 423 PRO GLU ASP LEU GLY CYS CYS LEU LEU LYS GLU TRP THR SEQRES 16 B 423 GLY LEU HIS ASP ALA TYR LEU GLU THR ARG ASP PHE LYS SEQRES 17 B 423 GLY SER GLU GLU GLY ASN THR MET VAL PRO LYS ASN CYS SEQRES 18 B 423 TYR VAL SER GLN GLN GLU LEU LYS PRO PHE PRO PHE GLY SEQRES 19 B 423 VAL ARG ILE ASP TYR VAL LEU TYR LYS ALA VAL SER GLY SEQRES 20 B 423 PHE TYR ILE SER CYS LYS SER PHE GLU THR THR THR GLY SEQRES 21 B 423 PHE ASP PRO HIS ARG GLY THR PRO LEU SER ASP HIS GLU SEQRES 22 B 423 ALA LEU MET ALA THR LEU PHE VAL ARG HIS SER PRO PRO SEQRES 23 B 423 GLN GLN ASN PRO SER SER THR HIS GLY PRO ALA GLU ARG SEQRES 24 B 423 SER PRO LEU MET CYS VAL LEU LYS GLU ALA TRP THR GLU SEQRES 25 B 423 LEU GLY LEU GLY MET ALA GLN ALA ARG TRP TRP ALA THR SEQRES 26 B 423 PHE ALA SER TYR VAL ILE GLY LEU GLY LEU LEU LEU LEU SEQRES 27 B 423 ALA LEU LEU CYS VAL LEU ALA ALA GLY GLY GLY ALA GLY SEQRES 28 B 423 GLU ALA ALA ILE LEU LEU TRP THR PRO SER VAL GLY LEU SEQRES 29 B 423 VAL LEU TRP ALA GLY ALA PHE TYR LEU PHE HIS VAL GLN SEQRES 30 B 423 GLU VAL ASN GLY LEU TYR ARG ALA GLN ALA GLU LEU GLN SEQRES 31 B 423 HIS VAL LEU GLY ARG ALA ARG GLU ALA GLN ASP LEU GLY SEQRES 32 B 423 PRO GLU PRO GLN PRO ALA LEU LEU LEU GLY GLN GLN GLU SEQRES 33 B 423 GLY ASP ARG THR LYS GLU GLN HET MG A 501 1 HET HP6 A 502 7 HET C14 A 503 14 HET C14 B 501 14 HET MG B 502 1 HET HP6 B 503 7 HETNAM MG MAGNESIUM ION HETNAM HP6 HEPTANE HETNAM C14 TETRADECANE FORMUL 3 MG 2(MG 2+) FORMUL 4 HP6 2(C7 H16) FORMUL 5 C14 2(C14 H30) HELIX 1 AA1 HIS A 25 SER A 41 1 17 HELIX 2 AA2 SER A 52 LEU A 63 1 12 HELIX 3 AA3 GLY A 110 GLY A 115 5 6 HELIX 4 AA4 TYR A 148 SER A 167 1 20 HELIX 5 AA5 ASP A 185 GLY A 196 1 12 HELIX 6 AA6 ALA A 200 THR A 204 1 5 HELIX 7 AA7 SER A 210 ASN A 214 5 5 HELIX 8 AA8 LEU A 302 GLY A 348 1 47 HELIX 9 AA9 ALA A 353 ASP A 401 1 49 HELIX 10 AB1 HIS B 25 SER B 41 1 17 HELIX 11 AB2 SER B 52 LEU B 63 1 12 HELIX 12 AB3 GLY B 110 GLY B 115 5 6 HELIX 13 AB4 TYR B 148 SER B 167 1 20 HELIX 14 AB5 ASP B 185 GLY B 196 1 12 HELIX 15 AB6 ALA B 200 THR B 204 1 5 HELIX 16 AB7 SER B 210 ASN B 214 5 5 HELIX 17 AB8 LEU B 302 GLY B 348 1 47 HELIX 18 AB9 ALA B 353 ASP B 401 1 49 SHEET 1 AA1 7 ALA A 69 PHE A 73 0 SHEET 2 AA1 7 LEU A 82 SER A 86 -1 O SER A 86 N ALA A 69 SHEET 3 AA1 7 LEU A 44 VAL A 50 -1 N ALA A 45 O PHE A 85 SHEET 4 AA1 7 SER A 6 GLY A 18 1 N PHE A 12 O LEU A 46 SHEET 5 AA1 7 LEU A 275 HIS A 283 -1 O ALA A 277 N ILE A 11 SHEET 6 AA1 7 PHE A 248 THR A 257 -1 N TYR A 249 O ARG A 282 SHEET 7 AA1 7 ASP A 206 LYS A 208 1 N ASP A 206 O PHE A 255 SHEET 1 AA2 6 GLU A 92 ILE A 97 0 SHEET 2 AA2 6 ALA A 117 LEU A 125 -1 O LEU A 120 N THR A 94 SHEET 3 AA2 6 MET A 128 HIS A 136 -1 O ALA A 132 N LEU A 121 SHEET 4 AA2 6 VAL A 172 ASP A 178 1 O LEU A 174 N TYR A 133 SHEET 5 AA2 6 ASP A 238 ALA A 244 -1 O LEU A 241 N LEU A 175 SHEET 6 AA2 6 HIS A 198 ASP A 199 -1 N HIS A 198 O TYR A 242 SHEET 1 AA3 7 ALA B 69 PHE B 73 0 SHEET 2 AA3 7 LEU B 82 SER B 86 -1 O SER B 86 N ALA B 69 SHEET 3 AA3 7 LEU B 44 VAL B 50 -1 N ALA B 45 O PHE B 85 SHEET 4 AA3 7 SER B 6 GLY B 18 1 N PHE B 12 O LEU B 46 SHEET 5 AA3 7 LEU B 275 HIS B 283 -1 O ALA B 277 N ILE B 11 SHEET 6 AA3 7 PHE B 248 THR B 257 -1 N TYR B 249 O ARG B 282 SHEET 7 AA3 7 ASP B 206 LYS B 208 1 N ASP B 206 O PHE B 255 SHEET 1 AA4 6 GLU B 92 ILE B 97 0 SHEET 2 AA4 6 ALA B 117 LEU B 125 -1 O LEU B 120 N THR B 94 SHEET 3 AA4 6 MET B 128 HIS B 136 -1 O ALA B 132 N LEU B 121 SHEET 4 AA4 6 VAL B 172 ASP B 178 1 O LEU B 174 N TYR B 133 SHEET 5 AA4 6 ASP B 238 ALA B 244 -1 O LEU B 241 N LEU B 175 SHEET 6 AA4 6 HIS B 198 ASP B 199 -1 N HIS B 198 O TYR B 242 LINK OE1 GLU A 49 MG MG A 501 1555 1555 2.83 LINK OE2 GLU A 49 MG MG A 501 1555 1555 2.47 LINK OE1 GLU B 49 MG MG B 502 1555 1555 2.83 LINK OE2 GLU B 49 MG MG B 502 1555 1555 2.47 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000